Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications

7 Jul 2025

Abstract excerpt

OBJECTIVE: Diabetic kidney disease (DKD) is increasingly recognized as a leading cause of chronic kidney disease (CKD) worldwide. Although N6-methyladenosine (m6A) mRNA modification is abundant in eukaryotes, its specific contribution to DKD pathogenesis is not well understood. This study aims to investigate the role of N6-methyladenosine (m6A) RNA modification patterns in DKD and their relationship with immune...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer-related gene regulation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40624623
DOI: 10.1186/s12882-025-04314-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implicationsPMID 40624623Read ↗

Functional methylome analysis of human diabetic kidney diseaseSemantic proximity Read ↗

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

Uncovering key markers and therapeutic targets for renal fibrosis in diabetic kidney disease through bulk and single-cell RNA sequencingSemantic proximity Read ↗

Integrative Omics Analyses Reveal Epigenetic Memory in Diabetic Renal Cells Regulating Genes Associated With Kidney DysfunctionSemantic proximity Read ↗

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

Advances in the Epigenetic Mechanisms of Diabetic Nephropathy PathogenesisSemantic proximity Read ↗

5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney diseaseSemantic proximity Read ↗

Epigenetic modification in diabetic kidney diseaseSemantic proximity Read ↗

Transcriptome-wide Landscape of RNA Modification N6-Methyladenosine in Chromophobe Renal Cell CarcinomaSemantic proximity Read ↗

Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)Semantic proximity Read ↗

The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitusSemantic proximity Read ↗

Identification of immune microenvironment and PANoptosis-related biomarkers in diabetic kidney disease: PSMB8 and PSMB9Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.